Invivyd, Inc.
Public company- Headquarters
- NEW HAVEN, Connecticut
- Industry
- Biotechnology
- Ticker
- IVVD
- CIK
- 0001832038
WARN notices since 2024
0
None on record
Workers affected since 2024
0
Across 0 notices
Executive changes, last 12 months
3
3 appointments, 0 departures
Last event
Sep 1, 2026
Executive appointmentCEO appointed: Marc Elia
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| CEOMarc Elia | Sep 1, 2026 | Appointed |
| Lead Independent DirectorAjay Royan | Sep 1, 2026 | Appointed |
| directorIan Sheffield | Sep 1, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- IRulya Therapeutics Inc.
CEO departs: Dirk Thye, M.D.
- ANAVEX LIFE SCIENCES CORP.
CEO appointed: Terrie Kellmeyer, Ph.D.
- RECURSION PHARMACEUTICALS, INC.
Chair of the Board appointed: Fred Hassan
- Vir Biotechnology, Inc.
Class III director appointed: Suzanne Topalian, M.D.
No events of this type on record.
Show all eventsLast verified Nov 8, 2026